You are here: Industry Insights > COVID-19 Vaccine

News List

EDQM releases updated pharmacopoeial quality standards for vaccines europeanpharmaceuticalreview
November 30, 2020
To aid COVID-19 vaccine developers, the EDQM has released an updated European Pharmacopoeia that can be accessed for free.
COVAXX commits to deliver 140 million COVID-19 vaccine doses to emerging markets europeanpharmaceuticalreview
November 30, 2020
The company suggests their experimental COVID-19 vaccine, UB-612, has the features and potential to disrupt the traditional vaccine distribution and supply status quo.
EU secures 80 million doses of Moderna COVID-19 vaccine europeanpharmaceuticalreview
November 30, 2020
The European Commission and Moderna have agreed that the company will supply at least 80 million doses of mRNA-1273, the company’s COVID-19 vaccine candidate.
WHO report suggests African countries are not ready for COVID-19 vaccines europeanpharmaceuticalreview
November 30, 2020
The WHO Regional Director for Africa urges governments to “ramp up readiness” as report suggests the region is not prepared for a COVID-19 vaccine roll-out.
AstraZeneca likely to conduct new global low-dose Covid-19 vaccine trial pharmaceutical-technology
November 30, 2020
AstraZeneca may initiate an additional global trial to evaluate the efficacy of its Covid-19 vaccine candidate, AZD1222, using a lower dosage.
Britain presses on with AstraZeneca vaccine amid questions over trial data expresspharma
November 30, 2020
Britain gave AstraZeneca’s COVID-19 vaccine a vote of confidence on Friday when it asked its regulator to assess the shot for a rollout after experts raised questions about trial data and the company said it may run another study to gauge efficacy.
Serum Institute says in active talks with Indian government around potential COVID-19 vaccines expresspharma
November 30, 2020
Serum Institute of India (SII) is in active discussions with the Indian government on pricing and distribution of potential COVID-19 vaccines, said Adar Poonawalla, Chief Executive SII.
Experts express need for traceability of COVID-19 vaccines expresspharma
November 27, 2020
Industry experts have urged the government bodies to consider the need to incorporate an end-to-end traceability mechanism on all COVID-19 vaccines.
Covaxx announces Covid-19 vaccine purchase deals worth $2.8bn pharmaceutical-technology
November 27, 2020
US company COVAXX has announced $2.8bn advanced purchase commitments of over 140 million doses of its UB-612 vaccine to be delivered in countries including Brazil, Ecuador and Peru.
Altimmune submits FDA application for intranasal Covid-19 vaccine candidate pharmaceutical-technology
November 27, 2020
Altimmune has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) to start a Phase I clinical study of its Covid-19 vaccine candidate.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page